Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese.
about
Identification of FAM111A as an SV40 host range restriction and adenovirus helper factorNascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork componentsIdentification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.Nonsyndromic cleft lip with or without cleft palate and cancer: Evaluation of a possible common genetic background through the analysis of GWAS dataProstate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Genetic causes of hypomagnesemia, a clinical overviewGenome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese.Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemiaGeneralizability of established prostate cancer risk variants in men of African ancestryProstate cancer in East Asia: evolving trend over the last decade.Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa.A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjectsScreening for familial and hereditary prostate cancer.A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions.Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations.Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortalityHOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants.Chromatin interactions and candidate genes at ten prostate cancer risk loci.Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk.Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.Prostate cancer risk-associated genetic markers and their potential clinical utilityAssociation of a common variant at 10q26 and benign prostatic hyperplasia aggressiveness in han chinese descent.A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.A genome-wide association study of prostate cancer in West African men.HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular surveyThe genetic epidemiology of prostate cancer and its clinical implications.Nucleic acid-based tissue biomarkers of urologic malignancies.Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.
P2860
Q24301654-B3DB74CC-CEAB-4420-8677-338D2BC12016Q24338173-88A7C821-C8AD-4FE4-93C0-A274BA10197FQ29417155-B6F929F4-99B2-4FD9-A335-7C642AE6E99FQ31130933-A27666E2-44B1-460A-8C53-83B29A49F50BQ33640983-5431D42D-F745-4228-9A9C-3DB40DD64054Q33715342-4BE9C12E-4653-442B-A249-ACCE39C08873Q33977740-C937BC62-6850-4211-817D-D5C6C28C7990Q34343197-8E603C58-193E-4076-89E7-BD9F6E830711Q34447165-2FB3D6F0-246E-482D-846B-4F961B246AE0Q34671698-8545AA6B-153C-4492-9A50-5FE3575A600BQ34716723-2F928EC5-278F-49FD-9BEB-9D071F9BEECFQ34927940-C3194233-8520-480B-8284-93188B2F8BDFQ35077079-97298EC5-469F-4B1D-B205-0003BD4846EAQ35248192-B8DA7683-F80C-4E48-B8CD-B45CE64165ABQ35646703-DD63D602-275B-40D9-8050-386141782812Q35817086-A8E3569B-9804-47A3-8FE6-9353FBC5DFBBQ35846834-27A81537-8AF5-433C-A0D3-20BE012AB077Q35861576-56D1D9F4-DA68-4991-999A-F499EBAF8D94Q35925225-6E272088-90C8-4C6B-A7FF-AB70E005AA25Q36065460-EB6D4E49-5E66-4401-B359-94972B1C0DF8Q36169063-1FFC2805-3374-41B3-A7C2-7D825AC9E40FQ36250030-FE56835B-8DFB-45DC-AD7F-1E381A7F48DFQ36286694-9BDC742E-878A-4C46-A8C9-E060805EEE06Q36503369-9CE060F1-3697-4B0C-977A-58C45155D23DQ36558326-9792D5C2-D120-44CC-95BB-BE209BBF2684Q36691160-B1C5C750-59AF-4642-9BA5-121BCDBCBE5DQ36758880-59045250-C6B1-4884-8383-A44BDEED1D2FQ36895709-E5305FB9-63A4-4FA3-80D9-46AED5B634D9Q36898448-35E64D0F-21BF-40E6-99A8-549415AF7EF1Q37085446-F4ADB082-1177-4E38-A4E1-D1CCE1A0AF89Q37105061-5F077A79-E284-4AC7-8C63-3350FFA59BB9Q37225298-062FED9F-7F02-4015-B204-C01042E23F5EQ37474516-C902ADF8-795E-48D2-A7F7-76FB4A034128Q37541989-98203DE8-C28D-4066-AB38-12DB741E722FQ37592171-4567A04D-4C17-432F-AD4F-44AE725AC97DQ37705188-D807057D-B635-4A19-9BD9-A8A3E3ADCCFCQ37705596-EC354794-A059-4743-A431-9AC751CE4888Q38168060-BC65A444-BCA9-4ED4-9520-6B405BBA1EF1Q38216131-5F2B732F-5FB6-474B-8A73-BF3347EBEEE7Q38264616-011E3D3F-E40A-412F-9791-5D0724D2B3AA
P2860
Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Common variants at 11q12, 10q2 ...... er susceptibility in Japanese.
@en
Common variants at 11q12, 10q2 ...... er susceptibility in Japanese.
@nl
type
label
Common variants at 11q12, 10q2 ...... er susceptibility in Japanese.
@en
Common variants at 11q12, 10q2 ...... er susceptibility in Japanese.
@nl
prefLabel
Common variants at 11q12, 10q2 ...... er susceptibility in Japanese.
@en
Common variants at 11q12, 10q2 ...... er susceptibility in Japanese.
@nl
P2093
P2860
P50
P356
P1433
P1476
Common variants at 11q12, 10q2 ...... er susceptibility in Japanese.
@en
P2093
Atsushi Takahashi
Gary K Chen
Hidewaki Nakagawa
Hiroki Yamada
Hiroyuki Takahashi
Johji Inazawa
Laurence N Kolonel
Michiaki Kubo
Minoru Yamakado
Mutsuo Furihata
P2860
P2888
P304
P356
10.1038/NG.1104
P407
P577
2012-02-26T00:00:00Z